Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

NCT07524101 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

1952

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency
Atherosclerosis
Dyslipidemia
Hypercholesterolemia
Cardiovascular Diseases

Interventions

DRUG: Moderate-intensity statin and ezetimibe combination therapy
DRUG: High-intensity statin monotherapy

Sponsor

Yonsei University